Viewing Study NCT03261167


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-05-05 @ 2:59 PM
Study NCT ID: NCT03261167
Status: COMPLETED
Last Update Posted: 2020-06-02
First Post: 2017-08-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase III Study to Evaluate the Efficacy and Safety of GSK1358820 in Subjects With Post-stroke Upper Limb Spasticity
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Spasticity, Post-Stroke View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Botulinum toxin A View
None Safety View
None post-stroke upper limb spasticity View
None Efficacy View
None GSK1358820 View
None double blind View